Zactima
Drug timelines are a Plus or Pro feature.
17 regulatory and trial events tracked for Zactima, covering 2009-06-23 to 2017-05-17. Get the full timeline:
Most recent: Clinical Trial Update: A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC) [Phase 1, Phase 2]